| KOTAK HEALTHCARE FUND
An open ended equity scheme investing in Pharma, Healthcare & allied sectors.
| KOTAK HEALTHCARE FUND
An open ended equity scheme investing in Pharma, Healthcare & allied sectors.

  

  
Investment Objective

The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly Pharma, Healthcare, and allied sectors. However, there is no assurance that the objective of the scheme will be achieved.

The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly Pharma, Healthcare, and allied sectors. However, there is no assurance that the objective of the scheme will be achieved.


Issuer/Instrument
% to Net
Assets

Equity & Equity related
Pharmaceuticals and Biotechnology 69.49
Sun Pharmaceuticals Industries Ltd. 13.05
JB CHEMICALS & PHARMACEUTICALS LTD. 5.93
Cipla Ltd. 5.51
Divi s Laboratories Ltd. 4.90
Lupin Ltd. 3.91
JUBILANT PHARMOVA LIMITED 3.26
GLAND PHARMA LIMITED 3.00
ANTHEM BIOSCIENCES LTD 2.79
DR REDDYS LABORATORIES LTD. 2.64
MANKIND PHARMA LTD 2.62
Alkem Laboratories Ltd. 2.57
ACUTAAS CHEMICALS LTD 2.56
Glenmark Pharmaceuticals Ltd 2.40
Aurobindo Pharma Ltd. 2.36
Ajanta Pharma Ltd. 2.33
SAI LIFE SCIENCES LIMITED 2.23
Marksans Pharma Ltd 1.78
INNOVA CAPTABS LTD 1.75
Zydus Lifesciences Limited 1.69
ORCHID PHARMA LTD. 1.51
HIKAL LTD 0.70
Healthcare Services 26.09
MAX HEALTHCARE INSTITUTE LTD. 7.33
Apollo Hospitals Enterprises Ltd. 4.23
Fortis Healthcare India Ltd 4.18
KRISHNA INSTITUTE OF MEDICAL 3.02
ASTER DM HEALTHCARE LTD 2.90
KRSNAA DIAGNOSTICS LTD 1.63
YATHARTH HOSPITAL AND TRAUMA CARE SERVICES LTD 1.44
RAINBOW CHILDRENS MEDICARE LTD 1.36
Healthcare Equipment and Supplies 2.10
LAXMI DENTAL LIMITED 2.10
Equity & Equity related - Total 97.68
Triparty Repo 2.56
Net Current Assets/(Liabilities) -0.24
Grand Total 100.00



Systematic Investment Plan (SIP) If you had invested Rs 10,000 every month
Monthly SIP of Rs 10000 Since Inception 1 Year
Total amount invested (₹) 2,20,000 1,20,000
Total Value as on Sep 30, 2025 (₹) 2,34,822 1,18,616
Scheme Returns (%) 7.01 -2.14
Nifty Healthcare Index (TRI) Returns (%) 9.42 1.06
Alpha* -2.41 -3.20
Nifty Healthcare Index (TRI) (₹)# 2,39,979 1,20,683
Nifty 50 (TRI) (₹)^ 2,32,908 1,23,248
Nifty 50 (TRI) Returns (%) 6.11 5.08

Scheme Inception : - December 11, 2023. The returns are calculated by XIRR approach assuming investment of ₹10,000/- on the 1st working day of every month. Since Inception returns are assumed to be starting from the inception date of the Scheme and calculated accordingly. XIRR helps in calculating return on investments given an initial and final value and a series of cash inflows and outflows and taking the time of investment into consideration. The SIP performance details provided herein are of Regular Plan - Growth Option Different plans have different expense structure. # Benchmark; ^ Additional Benchmark. TRI – Total Return Index, In terms of para 6.14 of SEBI Master circular No. SEBI/HO/IMD/IMD-PoD-1/P/CIR/2024/90 dated June 27, 2024, the performance of the scheme is benchmarked to the Total Return variant (TRI) of the Benchmark Index instead of Price Return Variant (PRI). Alpha is difference of scheme return with benchmark return. *All payouts during the period have been reinvested in the units of the scheme at the then prevailing NAV. Source: ICRA MFI Explorer.

Net Asset Value (NAV)
RegularDirect
Growth Rs13.1269Rs13.5232
IDCW Rs13.1311Rs13.5221
(as on September 30, 2025)

Available Plans/Options

A) Regular Plan B) Direct Plan
Options: Growth and Income Distribution cum capital withdrawal (IDCW) (Payout and Reinvestment)


Fund Manager* Ms. Shibani Sircar Kurian,
Mr. Abhishek Bisen &
Mr. Dhananjay Tikariha
BenchmarkNifty Healthcare Index TRI
Allotment dateDecember 11, 2023
AAUMRs475.69 crs
AUMRs464.13 crs
Folio count33,558

IDCW Frequency

Trustee's Discretion


Ratios
Portfolio Turnover26.63%
$Beta0.97
$Sharpe ##0.58
$Standard Deviation17.08%
^^(P/E) 38.79
^^P/BV 5.03
Source: $ICRA MFI Explorer, ^^Bloomberg

Market Capitalisation*
Large Cap45.88%
Mid Cap16.63%
Small Cap35.17%
Debt & Money Market2.32%

*% of Net Asset

Minimum Investment Amount

Initial & Additional Investment
• Rs100 and any amount thereafter
Systematic Investment Plan (SIP)
• Rs 100 and any amount thereafter

Ideal Investments Horizon

• 5 years & above


Load Structure

Entry Load: Nil. (applicable for all plans)
Exit Load:
• For redemption / switch out within 30 days from the date of allotment: 0.5%
• If units are redeemed or switched out on or after 30 days from the date of allotment: NIL


Total Expense Ratio**
Regular Plan: 2.40%
Direct Plan: 0.76%

Data as on 30th September, 2025 unless otherwise specified.

Folio Count data as on 29th August 2025.

Fund


Benchmark : Nifty Healthcare Index TRI
This product is suitable for investors who are seeking*:
  • Long-term capital growth
  • Investment in portfolio of predominantly equity & equity related securities of companies engaged in Pharma, Healthcare & allied sectors.

* Investors should consult their financial advisors if in doubt about whether the product is suitable for them.

For latest Riskometer, investors may refer to an addendum issued or updated on website at www.kotakmf.com

## Risk rate assumed to be 5.74% (FBIL Overnight MIBOR rate as on 30th Sep 2025). **Total Expense Ratio includes applicable GST.
* For Fund Manager experience, please refer 'For Regular Plan' & 'For Direct Plan'
For scheme performance, please refer 'For Regular Plan' & 'For Direct Plan'